Up Next
Back to Show
American Black Journal
FDA approves new gene therapies for sickle cell disease
Host Stephen Henderson examines the groundbreaking new gene therapies approved by the U.S. Food and Drug Administration as a treatment option for sickle cell disease. Dr. Melissa Creary, assistant professor at the University of Michigan’s School of Public Health, sits down with Henderson to talk about the pros, cons and possible barriers of the new gene-editing therapy.
Support Provided By
25:01
A Michigan COVID study, “Women of Excellence” recipients, and a tribute to Luther Keith.
26:46
The “Black Church in Detroit” series examines faith-based efforts to support youth mental health.
26:46
The Episcopal Diocese of Michigan’s Spirituality and Race initiative and foster care in Michigan.
26:45
Stephen Henderson learns about The Jackson Home and Black Leaders Detroit’s 2025 Ride for Equity.
26:46
“The Central Park Five” opera comes to Detroit and the 11th annual Small Business Workshop.
26:46
Easter season in the Black church and a conversation with jazz bassist Ron Carter.
26:46
A conversation with best-selling author and poet Kwame Alexander and details on Bookstock 2025.
26:46
Stephen Henderson talks with Eye Care For Detroit’s founder and cybersecurity expert Sakinah Tanzil.
26:45
Details about Grow Detroit’s Young Talent program and the resurgence of Detroit’s Avenue of Fashion.
26:46
The evolution and influence of funk music and Michigan Poet Laureate Melba Joyce Boyd.
26:46
The “Black Church in Detroit” series examines the role of Black women during the Great Migration.
25:00
A Michigan COVID study, “Women of Excellence” recipients, and a tribute to Luther Keith.